Prodigy Care Services

Prodigy Care Services A smart platform that enables sponsors to provide workers’ compensation pharmacy benefits, and concurrently extract vested financial value from the program.

Prodigy leads where others struggle—turning pharmacy chaos into clarity through embedded transparency, clinical precisio...
10/19/2025

Prodigy leads where others struggle—turning pharmacy chaos into clarity through embedded transparency, clinical precision, and strategy built for performance, not excuses. https://www.prodigycareservices.com/solutions

This Labor Day, we honor the unseen work behind every recovery. From adjusters and pharmacists to nurse case managers—yo...
08/31/2025

This Labor Day, we honor the unseen work behind every recovery. From adjusters and pharmacists to nurse case managers—your labor matters. To our team, our partners, and every frontline hero in workers’ comp—thank you.

Prodigy is headed to "WCI-Palooza”—let the comp chords play.We’re thrilled to be attending WCI this year at the Orlando ...
07/25/2025

Prodigy is headed to "WCI-Palooza”—let the comp chords play.
We’re thrilled to be attending WCI this year at the Orlando World Center Marriott. Click here to connect with the team: www.prodigycareservices.com/connect. We promise insights that hit all the right notes.

Is Black Lung another   blind spot in workers' comp? It's resurging in younger miners, driving up long-term disability a...
07/14/2025

Is Black Lung another blind spot in workers' comp? It's resurging in younger miners, driving up long-term disability and drug costs. Prevention is possible—if we act upstream. Pharmacists and payers must work together to flag risks early and manage chronic lung conditions before they spiral into costly, irreversible claims. Read more:
www.prodigycareservices.com/blog/whats-lurking-in-the-dust

GLP-1s are rewriting the rules—but every blockbuster drug deserves a second look. We’ve been flooded with questions abou...
07/06/2025

GLP-1s are rewriting the rules—but every blockbuster drug deserves a second look. We’ve been flooded with questions about long-term side effects of Ozempic, Wegovy, and other GLP-1s. So we went digging—not for anecdotes or headlines, but for actual data. Hype doesn’t equal harmless. Insight beats assumption. And in this case, evidence matters most.

https://www.prodigycareservices.com/blog/are-glp-1s-tb3bl

Honoring the freedom to build, innovate, and push forward. This Independence Day, we’re celebrating the momentum that mo...
07/04/2025

Honoring the freedom to build, innovate, and push forward. This Independence Day, we’re celebrating the momentum that moves us—all while staying grounded in purpose. Happy 4th from Team Prodigy. 🇺🇸

💉 GLP-1s: More Than a Blood Sugar StoryOzempic, Wegovy, and Mounjaro aren’t just making headlines for weight loss anymor...
06/29/2025

💉 GLP-1s: More Than a Blood Sugar Story
Ozempic, Wegovy, and Mounjaro aren’t just making headlines for weight loss anymore—they’re stepping into the ring as contenders in cardiovascular disease prevention. 📉❤️

Recent trials like SELECT and SUSTAIN-6 show these drugs can reduce heart attacks, strokes, and cardiovascular death—even in patients without diabetes.

But let’s not get carried away. SGLT-2s still outperform in heart failure. GLP-1s shine in stroke prevention for diabetics with heart disease. This isn’t one-size-fits-all—it’s precision prescribing.

🔍 As GLP-1 popularity soars, clinical discernment and payer oversight matter more than ever. This is where we come in. https://www.prodigycareservices.com/blog/are-glp-1s

The FDA has approved five major heart-related medications since 2020. These therapies bring game-changing outcomes for p...
06/22/2025

The FDA has approved five major heart-related medications since 2020. These therapies bring game-changing outcomes for patients—but also higher price tags, new mechanisms, and added complexity in workers’ comp claims.

🫀 Top Approvals (2020–2025):

Inpefa® (dual SGLT1/2) – Heart failure & diabetes
Wegovy® (GLP-1) – First weight loss drug approved for CV risk reduction
Entresto® – Now approved for both HFrEF and HFpEF
Camzyos® – First myosin inhibitor for oHCM
Verquvo® – Targets post-decompensated heart failure

https://www.prodigycareservices.com/blog/cardiovascular-disease-claims-in-workers-comp-5fe2h

Address

Houston, TX

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm
Saturday 9am - 12pm

Telephone

+17133226667

Alerts

Be the first to know and let us send you an email when Prodigy Care Services posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Prodigy Care Services:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram